Introduction
Cataract surgery is one of the most frequent operations. The natural lens is removed and to restore vision, an intraocular lens is placed into the capsular bag. With a certain frequency the so-called posterior capsular opacification (aftercataract) develops. This is caused by epithelium cells, which grow over the capsular bag. Caffeic acid phenethyl ester (CAPE) is one of the active compounds of propolis, which can be found in honeybee hives. It is known to be antimitogenic and anti-inflammatory and there are some indications, that CAPE can influence cell differentiation or proliferation. 
Methods
The amount of CAPE encapsulated in a poly(dimethyl siloxane) (PDMS) matrix was 5 % (w/w). To prepare the drug release system a Mixture of the 2 component PDMS and CAPE was casted into tubes with an inner diameter of 500 µm and cross-linked. For the investigation of the release the drug release systems were incubated in PBS buffers at 37 °C and samples were withdrawn according to a fixed time pattern. The concentrations were determined by means of HPLC.
Results
CAPE was released from the cylindrical drug delivery systems during a period of 4 weeks. The released quantities of CAPE decreases slowly over this period and an accurate evaluation of the release process shows that the drug delivery follows a diffusion-controlled mechanism.
Conclusion
CAPE was successfully released from a PDMS. Further experiments will be done to investigate the effect of CAPE released from the drug delivery system on lens epithelium cells. DOI 10.1515 DOI 10. /bmt-2012 
